Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.9K Sell
505
-10
-2% -$1.17K 0.02% 231
2026
Q1
$62K Buy
+515
New +$59.5K 0.02% 229
2025
Q4
Sell
-639
Closed -$53.7K 407
2025
Q3
$53.7K Hold
639
0.02% 231
2025
Q2
$50.6K Sell
639
-498
-44% -$39.6K 0.02% 233
2025
Q1
$102K Buy
1,137
+73
+7% +$6.82K 0.04% 150
2024
Q4
$106K Sell
1,064
-190
-15% -$19.6K 0.04% 144
2024
Q3
$142K Sell
1,254
-113
-8% -$13.4K 0.06% 117
2024
Q2
$175K Sell
1,367
-582
-30% -$75K 0.07% 112
2024
Q1
$256K Buy
1,949
+234
+14% +$28.8K 0.11% 90
2023
Q4
$187K Buy
+1,715
New +$178K 0.07% 146

Other funds holding MRK

Main Street Group's MRK Position: Q2 2026 in Review

Main Street Group reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $1.17K and leaving 505 shares worth $64.9K. The position accounts for 0.02% of the portfolio, ranked #231.

Main Street Group first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $256K in Q1 2024. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Main Street Group held 505 shares of Merck worth $64.9K as of Q2 2026.
  • Main Street Group sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.02% of Main Street Group's portfolio in Q2 2026, its #231 holding.
  • Main Street Group first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Merck position peaked at $256K in Q1 2024.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.